MIP-3 alpha/CCL20 L-ELISA human allows the quantification of MIP-3α Hu in serum, plasma or human cell culture medium. The dosage will only recognize natural and recombinant MIP-3α Hu. Principle of the L-ELISA method...
MIP-3 alpha/CCL20 L-ELISA human allows the quantification of MIP-3α Hu in serum, plasma or human cell culture medium. The dosage will only recognize natural and recombinant MIP-3α Hu. Principle of the L-ELISA (immuno-enzymatic test) solid phase sandwich for human MIP-3α is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bound to immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
The inflammatory protein of 3-alpha macrophages (MIP-3alpha), also known as CCL20, is expressed in the liver, lungs, lymph nodes and peripheral blood lymphocytes. MIP-3alpha is highly regulated by inflammatory signals and regulated by the anti-inflammatory cytokine IL-10. MIP3alpha signals via the protein-coupled G receptor, CCR6, and acts as a chemoattractant for lymphocytes and dendritic cells.
Sensitivity
Sensitivity of dosage: 1.5 ng/ml.
Measurement range
Dosing range: 0.8 to 600 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Sample volume: Plasma, 50 µl; serum, 50 µl; supernatant, 100 µl.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17175379 |
| Specifications |
| Accession number | Exode-1 beta-chemiokin; beta-chemiokin exodus-1; LARC chemokine CC; ST38 chemokine CC; chemokine C-C 20; chemokine ligand C-C 20; CCL20; CCL20(1-64); CCL20(1-67); CCL20(2-70); Ligand chemokin (C-C motif) 20; CKB4; Exodus; Exodus-1; LARC; Liver-regulated chemokine and |
| Dose range | 0.8 to 600 pg/ml |
| Sensitivity of the dosage | 1.5 ng/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P78556 |
| Gene symbol(s) | CCL20 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96-well pre-coated plate Standard Concentrate of dosing diluent Biotinylated detection antibody SAV-HRP Wash pad Chromogen Discontinue solution Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CCL20 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 µl; serum, 50 µl; supernatant, 100 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EHCCL20X5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.